
    
      A phase 3, national, multi-centre, 4-week, prospective, randomised, controlled,
      parallel-group, open trial of LEO 90100 foam versus DovobetÂ® ointment (both treatments
      containing calcipotriol hydrate plus betamethasone dipropionate) in Japanese subjects with
      psoriasis vulgaris.
    
  